NHS England delivered a talk on the changes to the GP contract for 2017/18 and what it will mean for practices at our first LMC Roadshows.
We can now release the highlights from the event and the main topics that were discussed.
You can also download the slides here
- Clear message regarding claims for childhood vacs and imms – 6 months max. as per SFE
- When will new GMS1 form be available? Looks like October 2017.
- Erosion of PMS premium. All to be under GMS contract by 2021. Comparisons are available and practices who are close are actively being informed by NHSE.
Practices encouraged to keep a close eye on Open Exeter statements. Timescale to move from PMS to GMS three months.
- Discussed the importance of completing the national Workforce Minimum Data Set to enable strategic workforce planning etc.
- Further clarity given regarding locum cover payments for sickness and maternity. Cover calculated on ‘time’ not necessarily covering same illness.
- Clarification over ‘full-time’ GP = 9 sessions and payments will follow the detail in the SFE.
- Practices reminded that the indemnity payment made at the start of the year to be shared between partners and salaried GPs.
- Practices reminded that a move to GMS may affect salaried GP contracts – must use BMA model contract or negotiate one with same or more beneficial terms.
- Practices were encouraged to submit nil returns on CQRS.
- It was commented on at both roadshows that the flexibility within the contract was decreasing i.e. services which had been enhanced services like the AUA has now been incorporated under Frailty within the global sum.
- Clarification was sought regarding the extended hours reimbursement and the criteria around the lunchtime/half day closing by some practices.
- Questions were asked around CQRS and where information was regarding what submissions were automatic extraction and which ones require manual submission. Richard Hobbs, NHSE England, detailed where the information was available and that that this was being updated monthly now to make things easier for practices.
- Attendees were curious as to the plans around QOF and it was stated that it was here to stay for the time being. The ‘devil is in the detail’ regarding QOF and there would need to be extensive discussions to ensure that the ‘quality’ measurements were still prescriptive.
- It was raised by attendees at both roadshows that there was still not enough detailed guidance regarding the Frailty tool and that the perception was that it would be used as a performance management tool rather than ensuring quality for patients.